Autolomous and Cellular Origins today announce end-to-end integration of their respective platforms, bringing full automation and digitisation to the entire cell therapy manufacturing process. This new scalable approach creates a connected manufacturing environment that gives developers greater standardisation, traceability and control across the entire manufacturing process.

cgtc smic 130126 4 (1)